Table 1.
Cancer site | Demographic variable | ACTUR
|
SEER
|
|||||
---|---|---|---|---|---|---|---|---|
Active Duty
|
Non-Active Duty
|
|||||||
N | % | N | % | N | % | |||
Breast | Age* | 18–39 | 407 | 52% | 1,591 | 10% | 12,608 | 6% |
40+ | 375 | 48% | 14,715 | 90% | 210,344 | 94% | ||
Race | White | 487 | 62% | 14,302 | 88% | 203,353 | 91% | |
Black | 295 | 38% | 2,004 | 12% | 19,599 | 9% | ||
Cervix | Age* | 18–29 | 39 | 29% | 145 | 12% | 1,048 | 9% |
30–69 | 94 | 71% | 1,051 | 88% | 10,496 | 91% | ||
Race | White | 107 | 80% | 1,059 | 89% | 9,742 | 84% | |
Black | 26 | 20% | 137 | 11% | 1,802 | 16% | ||
Colorectum | Age* | 18–49 | 565 | 86% | 948 | 10% | 11,480 | 7% |
50+ | 92 | 14% | 8747 | 90% | 147,393 | 93% | ||
Race | White | 500 | 76% | 8,432 | 87% | 143,675 | 90% | |
Black | 157 | 24% | 1,263 | 13% | 15,197 | 10% | ||
Sex | Women | 69 | 11% | 3,679 | 38% | 78,896 | 50% | |
Men | 588 | 89% | 6,016 | 62% | 79,977 | 50% | ||
Prostate** | Age* | 18–49 | 413 | 51% | 423 | 2% | ||
50+ | 404 | 49% | 21444 | 98% | ||||
Race | White | 623 | 76% | 17,894 | 82% | |||
Black | 194 | 24% | 3,973 | 18% |
Age categories were cancer site specific based on American Cancer Society cancer screening recommendations.
Prostate cancer in SEER was not analyzed.